Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03529383Not ApplicableCompleted

Efficacy of Exercise Using Connected Activity Trackers and Therapeutic Education in Localized Breast Cancer

Role: collaborator

NCT02986763Completed

Evaluation of Pesticide Exposure in the General Population

Role: collaborator

NCT01489787Not ApplicableUnknown

Study to Evaluate a High Intensity Focused Ultrasound (HIFU) Procedure in Patient With Liver Metastases

Role: collaborator

NCT01331772Not ApplicableCompleted

Impact of Nutritional Intervention in Women With Breast Cancer Under Adjuvant Chemotherapy

Role: collaborator

All 4 trials loaded